Navigation Links
Evalve(R) Completes $60 Million Series D Financing
Date:11/27/2007

ing as an investor in this round of funding through his new fund, Emergent Medical Ventures.

"We welcome Ryan to the board where his expertise and experience will be an important resource for Evalve as we move forward toward commercialization," said Ms. Powell. "At the same time, we are pleased that Dr. Fogarty will continue to be involved with the company. His contributions have been a strong factor in our success throughout our history and in the development of the MitraClip device."

EVEREST Study Continues Enrollment

The EVEREST II study continues at more than 35 centers in North America with more than 300 patients enrolled and more than 300 MitraClip devices implanted to date. Investigators are currently enrolling patients in both arms of the EVEREST II study -- a randomized, controlled arm and a high risk registry arm -- with the goal of completing enrollment by the end of 2008.
Enrollment in the study is open to a range of patients:

-- Patients with either degenerative or functional MR.

-- Patients who are good surgical candidates and are open to the option

of a less invasive approach.

-- High risk patients who are not good candidates for surgery will be

enrolled in the EVEREST High Risk Registry until enrollment is

complete in this arm by the end of 2007.

The EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) randomized study is evaluating the safety and efficacy of the MitraClip device compared to surgical mitral valve repair or replacement. This prospective, randomized, multi-center study will enroll 279 patients at up to 42 sites in the United States and Canada. Patients are randomized 2:1 to receive the MitraClip device. Patients who are interested in participation in the study can call 1-877-MY-MR-FIX (1-877-696-7349). More information about the EVEREST II trial is available at http://www.mitralregur
'/>"/>

SOURCE Evalve, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Eligard(R) six-month formulation successfully completes European approval procedure
2. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
3. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
4. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
5. GSI Securitization Completes Merger and Domicile Transfer
6. Medical Services International Inc. Completes Testing for European Union (EU) Application
7. Inverness Completes Acquisition of Cholestech
8. Billians HealthDATA Completes Comprehensive Long Term Care Database Update
9. Synova Completes Sale of $3.3 Million in Senior Convertible Notes and Warrants
10. Explorer completes the map ... for the bodys blueprint
11. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Pyramid Analytics, worldwide leader in Governed ... of Veterans Affairs has selected Pyramid Analytics ... Business Intelligence platform. This partnership will enable the ... enabling more than 30,000 users with insights that ... and reporting capabilities. , The strategic selection comes ...
(Date:9/30/2014)... “Biology and botany are having ... “and it’s about naming rights.” , In ... on the Bryan William Brickner Blog, the focus ... of Health (PubMed). The post highlights five cannabinoid ... transitions, aging with THC, the wake-inducing effects of ...
(Date:9/30/2014)... September 30, 2014 A trailblazer at heart, ... seeks out upcoming medical breakthroughs in spine repairs. His ... seen in his patients in which he has implanted the ... its components are state-of-the art and mimic normal human disc ... has also been proven to be an exceptional replacement device ...
(Date:9/30/2014)... 30, 2014 3M has added four new ... bond tapes. 3M 5906 , 3M 5907 , ... conformable VHBs which help create the strongest bond possible to ... used for bonding to difficult surfaces such as paints, low ... 5907, 5908, and 5905 are designed specifically for electronic device ...
(Date:9/30/2014)... Dogs are social animals, and love to go everywhere with ... travelling from place to place. Many dog owners choose to ... this is not only unsafe for the dog, but unsafe ... shares with readers why keeping a dog restrained in a ... ways a dog can become injured by riding freely in ...
Breaking Medicine News(10 mins):Health News:U.S. Department of Veterans Affairs Takes Its Analytic Capabilities to the Next Level with BI Office from Pyramid Analytics 2Health News:Homeostasis: Publius’ Sleep Political Cannabinoid Science ~ New on the Bryan William Brickner Blog 2Health News:3M Releases New VHB™ Thin Foam Tapes as the Ultimate Electronics Bonding Solution 2Health News:3M Releases New VHB™ Thin Foam Tapes as the Ultimate Electronics Bonding Solution 3Health News:Royal Flush Havanese Offers Tops On the Importance of Restraining Dogs In Cars 2Health News:Royal Flush Havanese Offers Tops On the Importance of Restraining Dogs In Cars 3
... ... , ... , ... ...
... The adverse affects of being overweight are not limited to ... research in the latest issue of the Journals ... (Volume 65A, Number 1). The publication presents a collection ... older persons. "One of the unanticipated consequences of ...
... exposure time , TUESDAY, Feb. 23 (HealthDay News) -- ... as much as 91 percent less radiation than standard ... generated great enthusiasm in recent years, due to its ... coronary artery disease. However, that enthusiasm has been tempered ...
... to develop dementia than non-hospitalized, study finds , TUESDAY, ... hospitalized have an increased risk of cognitive decline. , That,s ... through 2007 on 2,929 people, aged 65 and older, who ... During an average follow-up of 6.1 years, 1,287 were hospitalized ...
... ... ... ... ...
... stress hormone levels in adolescent boys and girls but ... researchers. Early treatment of depression could help reduce stress ... "This is the first time cortisol reactivity has ... obesity in girls," said Elizabeth J. Susman, the Jean ...
Cached Medicine News:Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 2Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 3Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 4Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 5Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 6Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 7Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 8Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 9Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 10Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 11Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 12Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 13Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 14Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 15Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 16Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 17Health News:Universal Health Realty Income Trust Reports 2009 Fourth Quarter and Full Year Financial Results 18Health News:Overweight middle-aged adults at greater risk for cognitive decline in later life 2Health News:New Heart CT Scans Deliver Far Less Radiation: Study 2Health News:Hospital Stays May Spur Brain Decline in Seniors 2Health News:Stopain Labels Featuring Arthritis Foundation Sponsorship Now Appearing on Retail Shelves 2Health News:Stopain Labels Featuring Arthritis Foundation Sponsorship Now Appearing on Retail Shelves 3Health News:Stopain Labels Featuring Arthritis Foundation Sponsorship Now Appearing on Retail Shelves 4Health News:Stress hormone, depression trigger obesity in girls 2
(Date:9/29/2014)... , Sept. 29, 2014 Based on ... Frost & Sullivan recognises ADOCIA with the 2014 ... Leadership. By adopting a flexible business model that ... the pharmaceutical industry, ADOCIA has managed to maintain ... proteins space. "ADOCIA,s core technology is ...
(Date:9/29/2014)... , Sept. 29, 2014  On Oct. 2, ... participate in the company,s seventh Global Day of Service. ... employees will join together in a single, coordinated effort ... play. "I,m so proud of this ... talent and energy to strengthening the communities around the ...
(Date:9/29/2014)... 2014 Kush Bottles, North America,s ... and consulting services for the medical and recreational marijuana ... has assumed the role of Chief Executive Officer. ... and worked as COO until February of 2014, returned ... other ventures. His return marks a clear dedication to ...
Breaking Medicine Technology:Frost & Sullivan Confers Technology Innovation Leadership Award on ADOCIA for its Robust Pipeline of Novel Therapeutic Proteins 2Frost & Sullivan Confers Technology Innovation Leadership Award on ADOCIA for its Robust Pipeline of Novel Therapeutic Proteins 3Frost & Sullivan Confers Technology Innovation Leadership Award on ADOCIA for its Robust Pipeline of Novel Therapeutic Proteins 4Frost & Sullivan Confers Technology Innovation Leadership Award on ADOCIA for its Robust Pipeline of Novel Therapeutic Proteins 5Frost & Sullivan Confers Technology Innovation Leadership Award on ADOCIA for its Robust Pipeline of Novel Therapeutic Proteins 6Lilly's seventh Global Day of Service rallies 24,000 employees in nearly 60 countries 2Lilly's seventh Global Day of Service rallies 24,000 employees in nearly 60 countries 3Kush Bottles Co-Founder Steps into Role of CEO 2
... Target Enrollment Expected in Fourth Quarter, BERKELEY ... GNTA ) announced that the Data Safety Monitoring ... Genasense (oblimersen sodium),Injection, which is the Company,s lead ... as originally planned after initial review of,blinded safety ...
... unique Ranexa(R) mechanism of action -, CHICAGO, March ... today that ranolazine significantly (p<0.001),shortened the QT interval of ... LQT3, which is caused by a genetic mutation in ... rhythm problems, including,sudden death. Ranolazine also shortened cardiac relaxation ...
Cached Medicine Technology:DSMB Supports Continuation of Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma 2DSMB Supports Continuation of Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma 3DSMB Supports Continuation of Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma 4Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in Study of Patients With Genetic Sodium Channel Disorder 2Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in Study of Patients With Genetic Sodium Channel Disorder 3
... Elite II features a diagnostic ... of Glasgow,(UG) algorithm. Unlike competitive ... age, the UG,algorithm bases its ... gender, age, race, medication,and classification., ...
... test face is a LogMAR ... Landolt C in various orientations ... targets are presented at 10% ... useful for evaluating the low ...
The CSV-1000-1.5CPD is a special test face designed specifically for Food and Drug Administration clinical trials., ,At the recommended test distance of 8 feet, the gratings test one spatial frequenc...
... test face is used widely for screening ... LogMAR acuity from 20/10 to 20/100 and ... cycles/degree. , ,The patient can be easily ... acuity and contrast sensitivity. If a contrast ...
Medicine Products: